Belite Bio (BLTE) Other Accumulated Expenses (2021 - 2025)

Belite Bio has reported Other Accumulated Expenses for 5 years, with the latest figure at $5000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Accumulated Expenses fell 98.27% year-over-year to $5000.0; the trailing twelve-month figure through Dec 2025 stood at $5000.0 (down 98.27% YoY), and the FY2025 full-year result was $5000.0, down 98.27% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $5000.0, down from $289000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $289000.0 in Q4 2024, with the low at $5000.0 in Q4 2025.
• Average Other Accumulated Expenses over 5 years is $122400.0, with a median of $95000.0 recorded in 2021.
• Year-over-year, Other Accumulated Expenses jumped 101.35% in 2023 and plunged 98.27% in 2025.
• Tracing BLTE's Other Accumulated Expenses over 5 years: stood at $95000.0 in 2021, then slipped by 22.11% to $74000.0 in 2022, then jumped by 101.35% to $149000.0 in 2023, then soared by 93.96% to $289000.0 in 2024, then sank by 98.27% to $5000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $5000.0 (Q4 2025), $289000.0 (Q4 2024), and $149000.0 (Q4 2023), per Business Quant data.

Peer Comparison